Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis
- PMID: 17644191
- DOI: 10.1016/j.ijporl.2007.06.006
Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis
Abstract
The causes of penicillin failure in eradicating Group A beta-hemolytic streptococcal pharyngo-tonsillitis (GABHS PT) are described. These include the presence of beta-lactamase producing bacteria that "protect" Group A beta-hemolytic streptococci (GABHS) from penicillins; the absence of bacteria that interfere with the growth of GABHS; co-aggregation between GABHS and Moraxella catarrhalis; and the poor penetration of penicillin into the tonsillar tissues and the tonsillo-pharyngeal cells. The use of antimicrobials that can overcome and modulate these phenomena and achieve better cure of the infection is described.
Similar articles
-
Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.J Fam Pract. 1994 Feb;38(2):175-9. J Fam Pract. 1994. PMID: 8308510 Review.
-
Failure to eradicate streptococci and beta-lactamase producing bacteria.Acta Paediatr. 2008 Feb;97(2):193-5. doi: 10.1111/j.1651-2227.2007.00610.x. Acta Paediatr. 2008. PMID: 18254908
-
Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group A beta-haemolytic streptococci in healthy children and those with pharyngo-tonsillitis.J Med Microbiol. 2006 Aug;55(Pt 8):989-992. doi: 10.1099/jmm.0.46325-0. J Med Microbiol. 2006. PMID: 16849717
-
[Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy].Med Pregl. 1998 May-Jun;51(5-6):275-8. Med Pregl. 1998. PMID: 9720358 Croatian.
-
Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.Pediatr Infect Dis J. 2004 Feb;23(2 Suppl):S129-34. doi: 10.1097/01.inf.0000112527.33870.0d. Pediatr Infect Dis J. 2004. PMID: 14770076 Review.
Cited by
-
A survey of antibiotic resistance patterns among Group A Streptococcus isolated from invasive and non-invasive infections in Cape Town, South Africa.Heliyon. 2024 Jun 26;10(13):e33694. doi: 10.1016/j.heliyon.2024.e33694. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040411 Free PMC article.
-
Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread.J Clin Microbiol. 2020 Mar 25;58(4):e01993-19. doi: 10.1128/JCM.01993-19. Print 2020 Mar 25. J Clin Microbiol. 2020. PMID: 31996443 Free PMC article.
-
In Vivo Secretion of β-Lactamase-Carrying Outer Membrane Vesicles as a Mechanism of β-Lactam Therapy Failure.Membranes (Basel). 2021 Oct 23;11(11):806. doi: 10.3390/membranes11110806. Membranes (Basel). 2021. PMID: 34832035 Free PMC article.
-
StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.PLoS One. 2013 Apr 8;8(4):e60969. doi: 10.1371/journal.pone.0060969. Print 2013. PLoS One. 2013. PMID: 23593359 Free PMC article.
-
Synergy and Mode of Action of Ceftazidime plus Quercetin or Luteolin on Streptococcus pyogenes.Evid Based Complement Alternat Med. 2015;2015:759459. doi: 10.1155/2015/759459. Epub 2015 Oct 21. Evid Based Complement Alternat Med. 2015. PMID: 26576195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical